B&l Asset Management »

Vertex Pharmaceuticals Incorporated shares owned by B&l Asset Management

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by B&l Asset Management from 13F filings

Historical chart of B&l Asset Management investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by B&l Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by B&l Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.9M 6.1k 465.08

More positions owned by B&l Asset Management

Broadcom (AVGO)
Microsoft Corporation (MSFT)
Novo-nordisk A S Adr (NVO)
Mastercard Incorporated Cl A (MA)
AutoZone (AZO)
TJX Companies (TJX)
Thermo Fisher Scientific (TMO)
Costco Wholesale Corporation (COST)
Nxp Semiconductors N V (NXPI)
Travelers Companies (TRV)
Procter & Gamble Company (PG)
UnitedHealth (UNH)
Raytheon Technologies Corp (RTX)
JPMorgan Chase & Co. (JPM)
Chevron Corporation (CVX)

View all positions for B&l Asset Management

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
State Street Corporation
Capital Research Global Investors
FMR
Jpmorgan Chase & Co
Wellington Management Company
Geode Capital Management
Jennison Associates
Alliancebernstein
Loomis, Sayles and
Norges Bank Investment Management
Amundi
Morgan Stanley

View all funds holding Vertex Pharmaceuticals Incorporated